5 ESSENTIAL ELEMENTS FOR CHIR-090

Probable predictive biomarkers for tumor reaction to mTOR inhibitors, as have already been described in glioblastoma, breast and prostate most cancers cells, will be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[1] Therefore, this knowledge is based on preclinical assays, depending on in vitro cultured tumor cell lines, w